July is Fibroid Awareness Month – a global observance dedicated to raising awareness of uterine fibroids, the most common benign tumors affecting women of reproductive age. First established through advocacy efforts by women's health organizations and legislative resolutions in multiple states, this month serves as a critical platform to break the silence surrounding a condition that impacts millions—yet remains widely misunderstood and under-discussed.
The Need for Better Options
While treatment options exist—ranging from hormonal medical therapies to surgical interventions including myomectomy and hysterectomy—hysterectomy remains the most common treatment worldwide. For the millions of women who wish to preserve their fertility or simply retain their uterus, the need for effective, uterine‑sparing, minimally invasive solutions has never been greater.
Hysteroscopic myomectomy is the preferred treatment for submucous fibroids, the rarest but most symptomatic type that can lead to abnormal uterine bleeding and play a role in infertility and miscarriage. However, the complexity and variability of procedures call for advanced, reliable technologies that enhance precision, efficiency, and patient safety.
Our Commitment: Turning Awareness into Action
At Scivita Medical , we are dedicated to advancing gynecological care through innovation. This Fibroid Awareness Month, we are proud to introduce an integrated solution designed for both diagnostic exploration and therapeutic resection of submucous uterine fibroids: our Single‑Use Rigid Hysteroscope combined with the Omni Power System.
The Single‑Use Rigid Hysteroscope – Clarity and Safety from Diagnosis to Treatment
Our single‑use rigid hysteroscope is engineered for exceptional optical performance and ergonomic handling. Featuring high‑definition optics with a wide field of view, it delivers crisp, detailed images of the uterine cavity—enabling physicians to accurately identify fibroid locations, sizes, and morphology during diagnostic hysteroscopy. The rigid shaft provides stable maneuverability, facilitating smooth passage through the cervical canal and optimal positioning within the uterine cavity.
The single‑use design eliminates the risks of cross‑contamination and infection transmission associated with reusable scopes, while also removing the logistical burden and cost of reprocessing, sterilization, and maintenance. Every procedure starts with a sterile, factory‑calibrated device that ensures consistent image quality and performance, procedure after procedure.
Seamless Integration with the Omni Power System for Surgical Resection
Beyond diagnosis, the same hysteroscope pairs directly with our Omni Power System to enable a complete surgical workflow. Once a fibroid is identified, the physician can proceed immediately to resection without changing scopes or interrupting the procedure. The rigid hysteroscope provides a stable working channel for the shaver/morcellator, while the Omni Power System delivers the driving force and integrated fluid management required for safe, effective tissue removal.
What sets the Omni Power System apart?
⚙️ Integrated 3‑in‑1 Functionality – a true innovation in hysteroscopic surgery:
Irrigation – Uterine expansion for optimal visualization and surgical space
Suction – Efficient removal of fluid and tissue debris for a clear operative field
Shaver/Morcellation – Precise, layer‑by‑layer tissue shaving and removal
This all‑in‑one integration eliminates the need for multiple device switches during surgery, reducing procedure time, minimizing operational risk, and enhancing both efficiency and safety. When combined with our single‑use rigid hysteroscope, the system offers a seamless transition from diagnostic exploration to therapeutic morcellation—all within a single, sterile, user‑friendly setup.
Preserving the Uterus. Restoring Quality of Life.
We believe women deserve treatment options that do not come at the cost of their reproductive health or quality of life. The Omni Power System and our single‑use rigid hysteroscope reflect our commitment to that vision—delivering minimally invasive, uterine‑preserving care for women living with fibroids.
This Fibroid Awareness Month, we stand with patients, providers, and advocates in the fight for better fibroid care. Awareness is the first step. Innovation is the next.
To learn more about our integrated solution, please visit the product page. https://scivitamedical.com/product/?pro=1&cata=1
